Shopping Cart 0
Cart Subtotal
USD 0

Neuralstem Inc (CUR)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Neuralstem Inc (Neuralstem) is a developer of medicines for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer's disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, Parkinson's disease, huntington's disease and cerebral palsy, among others. It provides drug treatment for depressive disorder, cognitive complication due to diabetes, post traumatic stress disorder, neurodegeneration and anti aging. The company develops methods to generate replacement cells from neural stem cells. Neuralstem is headquartered in Germantown, Maryland, the US.

Neuralstem Inc (CUR)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Neuralstem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Neuralstem Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Neuralstem Inc, Medical Equipment, Deal Details 10

Partnerships 10

Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10

Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11

Equity Offering 11

Neuralstem Raises USD8 Million in Public Offering of Shares 11

Neuralstem to Raise up to USD20 Million in Public Offering of Shares 13

Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 14

Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 15

Neuralstem Inc-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Financial Announcements 20

May 10, 2017: Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update 20

Mar 23, 2017: Neuralstem Reports Year End 2016 Fiscal Results and Business Update 22

Nov 08, 2016: Neuralstem Reports Third Quarter 2016 Results 24

Aug 11, 2016: Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates 26

May 09, 2016: Neuralstem Reports Fiscal First Quarter 2016 Results and Business Update 28

Mar 14, 2016: Neuralstem Reports Fourth Quarter and Year End 2015 Fiscal Results and Business Update 30

Corporate Communications 32

Feb 16, 2016: Neuralstem Appoints Richard Daly as President and Chief Executive Officer 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Neuralstem Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Neuralstem Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Neuralstem Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Neuralstem Inc, Medical Equipment, Key Facts, 2016 1

Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Neuralstem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Neuralstem Inc, Deals By Market, 2011 to YTD 2017 8

Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10

Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11

Neuralstem Raises USD8 Million in Public Offering of Shares 11

Neuralstem to Raise up to USD20 Million in Public Offering of Shares 13

Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 14

Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 15

Neuralstem Inc, Key Competitors 17

Neuralstem Inc, Key Employees 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Neuralstem Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Neuralstem Inc (Neuralstem) is a developer of medicines for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer's disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, Parkinson's disease, huntington's disease and cerebral palsy, among others. It provides drug treatment for depressive disorder, cognitive complication due to diabetes, post traumatic stress disorder, neurodegeneration and anti aging. The company develops methods to generate replacement cells from neural stem cells. Neuralstem is headquartered in Germantown, Maryland, the US.

Neuralstem Inc (CUR)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Neuralstem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Neuralstem Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Neuralstem Inc, Medical Equipment, Deal Details 10

Partnerships 10

Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10

Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11

Equity Offering 11

Neuralstem Raises USD8 Million in Public Offering of Shares 11

Neuralstem to Raise up to USD20 Million in Public Offering of Shares 13

Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 14

Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 15

Neuralstem Inc-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Financial Announcements 20

May 10, 2017: Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update 20

Mar 23, 2017: Neuralstem Reports Year End 2016 Fiscal Results and Business Update 22

Nov 08, 2016: Neuralstem Reports Third Quarter 2016 Results 24

Aug 11, 2016: Neuralstem Reports Second Quarter 2016 Results and Provides Business and Clinical Updates 26

May 09, 2016: Neuralstem Reports Fiscal First Quarter 2016 Results and Business Update 28

Mar 14, 2016: Neuralstem Reports Fourth Quarter and Year End 2015 Fiscal Results and Business Update 30

Corporate Communications 32

Feb 16, 2016: Neuralstem Appoints Richard Daly as President and Chief Executive Officer 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Neuralstem Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Neuralstem Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Neuralstem Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Neuralstem Inc, Medical Equipment, Key Facts, 2016 1

Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Neuralstem Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Neuralstem Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Neuralstem Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Neuralstem Inc, Deals By Market, 2011 to YTD 2017 8

Neuralstem Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10

Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11

Neuralstem Raises USD8 Million in Public Offering of Shares 11

Neuralstem to Raise up to USD20 Million in Public Offering of Shares 13

Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 14

Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 15

Neuralstem Inc, Key Competitors 17

Neuralstem Inc, Key Employees 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Neuralstem Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat